For InVivage, the two conditions for registering are:
During the period Optiscan commenced the third party validation and verification testing required to be completed for the 510(k) submission. Optiscan and the Melbourne Dental School also commenced the dosing study for the topical use of fluorescein, indicated by the FDA as one of the requirements for Optiscan’s intended 510(k) application."
For Fluorescein - see this study from Memorial Sloan Kattering
https://www.researchsquare.com/article/rs-252422/v1
- Forums
- ASX - By Stock
- Tiresias - right instrument, right field, right moment
For InVivage, the two conditions for registering are: During the...
Featured News
Add OIL (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $63.48M |
Open | High | Low | Value | Volume |
7.6¢ | 7.6¢ | 7.6¢ | $4.73K | 62.23K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 35991 | 7.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 37987 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 35991 | 0.076 |
1 | 41109 | 0.073 |
1 | 317043 | 0.072 |
1 | 98902 | 0.071 |
1 | 14500 | 0.069 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 37987 | 1 |
0.080 | 71112 | 1 |
0.081 | 124827 | 1 |
0.082 | 8905 | 1 |
0.083 | 97000 | 1 |
Last trade - 16.10pm 28/03/2024 (20 minute delay) ? |
|
|||||
Last
7.6¢ |
  |
Change
0.000 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
7.6¢ | 7.6¢ | 7.6¢ | 41271 | ||
Last updated 12.26pm 28/03/2024 ? |
Featured News
OIL (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online